Outcome of trabeculectomy with intraoperative mitomycin C for uveitic glaucoma

Canadian Journal of Ophthalmology

Volumn 42, Issue 1, 2007, Pages 89-94

  Noble, Jason ^a   Derzko Dzulynsky, Larissa ^a,b   Rabinovitch, Theodore ^a   Birt, Catherine ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

Glaucoma; Mitomycin C; Outcome; Trabeculectomy; Uveitis

Indexed keywords

FLUOROURACIL; MITOMYCIN C;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GLAUCOMA; HIGH RISK PATIENT; HUMAN; INTRAOCULAR PRESSURE; INTRAOPERATIVE PERIOD; MAJOR CLINICAL STUDY; MALE; SURVIVAL RATE; TRABECULOTOMY; TREATMENT OUTCOME; UVEITIS;

EID: 33947176162     PISSN: 00084182     EISSN: 17153360     Source Type: Journal    
DOI: 10.1139/I06-124     Document Type: Article

References (18)

1. Reynolds AC, Skuta GL. Clinical perspectives on glaucoma-filtering surgery: antiproliferative agents. Ophthalmol Clin North Am 2000;13:501-16.
2. Kok H, Barton K. Uveitic glaucoma. Ophthalmol Clin North Am 2002;15:375-87.
3. Panek WC, Holland GN, Lee DA, et al. Glaucoma in patients with uveitis. Br J Opthalmol 1990;74:223-7.
4. Yanoff M, Duker JS. Ophthalmology. 1st ed. London, UK: Mosby International Ltd; 1999.
5. Hill RA, Nguyen QH, Baerveldt G, Forster DJ, Minckler DS, Rao N, Lee M, Heuer DK. Trabeculectomy and Molteno implantation for glaucomas associated with uveitis. Ophthalmology 1993;100:903-8.
6. Towler HM, McCluskey P, Shaer B, Lightman S. Long-term follow-up of trabeculectomy with intraoperative 5-fluorouracil for uveitis-related glaucoma. Ophthalmology 2000;107:1822-8.
7. Stavrou P, Murray PI. Long-term follow-up of trabeculectomy without antimetabolites in patients with uveitis. Am J Ophthalmol 1999;128:434-9.
8. Patitsas CJ, Rockwood EJ, Meisler DM, Lowder CY. Glaucoma filtering surgery with postoperative 5-fluorouracil in patients with intraocular inflammatory disease. Ophthalmology 1992;99:594-9.
9. Da Mata A, Burk SE, Netland PA, Baltatzis S, Christen W, Foster CS. Management of uveitic glaucoma with Ahmed glaucoma valve implantation. Ophthalmology 1999;106:2168-72.
10. Molteno AC, Sayawat N, Herbison P. Otago glaucoma surgery outcome study: long-term results of uveitis with secondary glaucoma drained by Molteno implants. Ophthalmology 2001;108:605-13.
11. Skuta GL, Beeson CC, Higginbotham EJ, et al: Intraoperative mitomycin versus postoperative 5-fluorouracil in high-risk glaucoma filtering surgery. Ophthalmology 1992;99:438-44.
12. Katz GJ, Higginbotham EJ, Lichter PR, et al: Mitomycin C versus 5-fluorouracil in high-risk glaucoma filtering surgery: extended follow-up. Ophthalmology 1995;102:1263-9.
13. Kitazawa Y, Kawase K, Matsushita H, et al: Trabeculectomy with mitomycin: a comparative study with fluorouracil. Arch Ophthalmol 1991;109:1693-8.
14. Lamping KA, Belkin JK: 5-Fluorouracil and mitomycin C in pseudophakic patients. Ophthalmology 1995;102:70-5.
15. Prata JA Jr, Neves RA, Minckler DS, Mermoud A, Heuer DK. Trabeculectomy with mitomycin C in glaucoma associated with uveitis. Ophthalmic Surg 1994;25:616-20.
16. Wright MM, McGehee RF, Pederson JE. Intraoperative mitomycin-C for glaucoma associated with ocular inflammation. Ophthalmic Surg Lasers 1997;28:370-6.
17. Ceballos EM, Beck AD, Lynn MJ. Trabeculectomy with antiproliferative agents in uveitic glaucoma. J Glaucoma 2002;11:189-96.
18. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. The AGIS Investigators. Am J Ophthalmol 2000;130:429-40.